美股财报 | 莱斯康制药发布Q2财报前半年累计净亏损同比缩小78.35%

同花顺iNews08-07

莱斯康制药(LXRX)发布Q2财报，2025财年前六月累计收入3012.80万美元，去年同期累计收入为277.70万美元，同比增长984.91%。2025财年前六月累计净亏损2204.30万美元，去年同期累计净亏损为1.02亿美元，同比缩小78.35%。本财年累计基本每股收益为-0.06美元，去年同期为-0.37美元。公司所属行业为生物科技。【公司信息】Lexicon ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2557538640?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-07 12:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2557538640","market":"us","top_or_hot":-1,"title":"美股财报 | 莱斯康制药发布Q2财报 前半年累计净亏损同比缩小78.35%","media":"同花顺iNews","content":"<div>\n<p>莱斯康制药(LXRX)发布Q2财报，2025财年前六月累计收入3012.80万美元，去年同期累计收入为277.70万美元，同比增长984.91%。2025财年前六月累计净亏损2204.30万美元，去年同期累计净亏损为1.02亿美元，同比缩小78.35%。本财年累计基本每股收益为-0.06美元，去年同期为-0.37美元。公司所属行业为生物科技。【公司信息】Lexicon ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807120604a6d7e0da&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股财报 | 莱斯康制药发布Q2财报 前半年累计净亏损同比缩小78.35%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股财报 | 莱斯康制药发布Q2财报 前半年累计净亏损同比缩小78.35%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-07 12:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807120604a6d7e0da&s=b><strong>同花顺iNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>莱斯康制药(LXRX)发布Q2财报，2025财年前六月累计收入3012.80万美元，去年同期累计收入为277.70万美元，同比增长984.91%。2025财年前六月累计净亏损2204.30万美元，去年同期累计净亏损为1.02亿美元，同比缩小78.35%。本财年累计基本每股收益为-0.06美元，去年同期为-0.37美元。公司所属行业为生物科技。【公司信息】Lexicon ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807120604a6d7e0da&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LXRX","symbol_name":"莱斯康制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807120604a6d7e0da&s=b","article_id":"2557538640","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807120604a6d7e0da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2557538640","pubTimestamp":1754539216,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"莱斯康制药发布Q2财报，2025财年前六月累计收入3012.80万美元，去年同期累计收入为277.70万美元，同比增长984.91%。2025财年前六月累计净亏损2204.30万美元，去年同期累计净亏损为1.02亿美元，同比缩小78.35%。公司所属行业为生物科技。Lexicon Pharmaceuticals, Inc.是一家生物制药公司，专注于研究并实现人类疾病在治疗上的突破。对于那些被认定有很高药用价值的靶标，其致力于对潜在新药物的研制计划。该公司于1995年7月7日在美国特拉华州成立，并于1995年9月开始营运。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"LXRX":"莱斯康制药"},"translate_title":"U.S. stock financial report | Lescom Pharmaceuticals releases Q2 financial report, the cumulative net loss in the first half of the year narrowed by 78.35% year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LXRX":1},"content_text":"莱斯康制药(LXRX)发布Q2财报，2025财年前六月累计收入3012.80万美元，去年同期累计收入为277.70万美元，同比增长984.91%。2025财年前六月累计净亏损2204.30万美元，去年同期累计净亏损为1.02亿美元，同比缩小78.35%。本财年累计基本每股收益为-0.06美元，去年同期为-0.37美元。公司所属行业为生物科技。【公司信息】Lexicon Pharmaceuticals, Inc.是一家生物制药公司，专注于研究并实现人类疾病在治疗上的突破。通过基因敲除技术和先进的医疗技术综合平台，该公司已经系统研究了小白鼠体内近5000个基因的生理和行为功能，且评估了由相应的人类基因作为潜在药物靶标所编码的蛋白质的效用，并且已经在活体（或活的有机体）内确定并验证了100多个能很好地应用于药物发现的靶标。对于那些被认定有很高药用价值的靶标，其致力于对潜在新药物的研制计划。该公司于1995年7月7日在美国特拉华州成立，并于1995年9月开始营运。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2557538640","isCrawlerRequest":true}

美股财报 | 莱斯康制药发布Q2财报 前半年累计净亏损同比缩小78.35%

精彩评论

美股财报 | 莱斯康制药发布Q2财报前半年累计净亏损同比缩小78.35%